

October 6, 2022
Kick-Off Meeting of the Consortium in Milan
In a pre-meeting to the highly anticipated 1st International DeltaCure conference, the D-SOLVE Consortium marked its inception with a kick-off gathering on October 6, 2022, in Milan. The consortium, focused on addressing the complex challenges posed by Hepatitis D, brought together prominent researchers, healthcare professionals, and stakeholders.
This pre-meeting served as a platform for collaborative discussions and laid the foundation for future research endeavors aimed at understanding and combating Hepatitis D. Participants engaged in insightful exchanges, shared expertise, and outlined the vision and goals of the consortium. With a focus on fostering innovation and establishing a united approach, the event set a promising tone for the following DeltaCure conference, where further advancements and breakthroughs in Hepatitis D research were anticipated to be unveiled.
October 6, 2022
Kick-Off Meeting of the Consortium in Milan
In a pre-meeting to the highly anticipated 1st International DeltaCure conference, the D-SOLVE Consortium marked its inception with a kick-off gathering on October 6, 2022, in Milan. The consortium, focused on addressing the complex challenges posed by Hepatitis D, brought together prominent researchers, healthcare professionals, and stakeholders.
This pre-meeting served as a platform for collaborative discussions and laid the foundation for future research endeavors aimed at understanding and combating Hepatitis D. Participants engaged in insightful exchanges, shared expertise, and outlined the vision and goals of the consortium. With a focus on fostering innovation and establishing a united approach, the event set a promising tone for the following DeltaCure conference, where further advancements and breakthroughs in Hepatitis D research were anticipated to be unveiled.
October 6, 2022
Kick-Off Meeting of the Consortium in Milan
In a pre-meeting to the highly anticipated 1st International DeltaCure conference, the D-SOLVE Consortium marked its inception with a kick-off gathering on October 6, 2022, in Milan. The consortium, focused on addressing the complex challenges posed by Hepatitis D, brought together prominent researchers, healthcare professionals, and stakeholders.
This pre-meeting served as a platform for collaborative discussions and laid the foundation for future research endeavors aimed at understanding and combating Hepatitis D. Participants engaged in insightful exchanges, shared expertise, and outlined the vision and goals of the consortium. With a focus on fostering innovation and establishing a united approach, the event set a promising tone for the following DeltaCure conference, where further advancements and breakthroughs in Hepatitis D research were anticipated to be unveiled.